Floatz logo

IMMUNOGLOBULIN G2, ANTI-(HUMAN NERVE GROWTH FACTOR) (HUMAN MONOCLONAL 4D4 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL 4D4 LIGHT CHAIN, DIMER

Osteoarthritis

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.monoclonal_antibodyPhase 2Dormant
C
33/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
18/ 100
Competitive Position
89/ 100

Competitive context

15 Active assets in the Osteoarthritis cohort.

Asset / SponsorPhaseRating
Buprenorphine
Mundipharma Pte Ltd.
Phase 4BBB
Naltrexone
Brigham and Women's Hospital
Phase 4BBB
Oxycodone
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Phase 4BBB
FENTANYL
Janssen Pharmaceutica
Phase 4BBB
Duloxetine
The Catholic University of Korea
Phase 4BBB

View all 48 →

Same molecule, other indications

IMMUNOGLOBULIN G2, ANTI-(HUMAN NERVE GROWTH FACTOR) (HUMAN MONOCLONAL 4D4 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL 4D4 LIGHT CHAIN, DIMER is also rated in:

Pain, CrushingDormant
C
Indicative ·
35 / 100
View asset →
Pain, MigratoryDormant
C
Indicative ·
35 / 100
View asset →
complex regional pain syndrome type 2Dormant
C
Indicative ·
35 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →